Clinical Outcomes of NovoSeven® Treatment in Severe Postpartum Haemorrhage - a Study at the University Hospital of Bern

Severe Postpartum Haemorrhage Clinical Trial

Official title: Clinical Outcomes of NovoSeven® Treatment in Severe Postpartum Haemorrhage - a Retrospective Single-centre Cohort Study at the University Hospital of Bern

Status Completed

Clinical Trial Summary

This non-interventional study will compare the clinical outcomes in women with an event of severe postpartum haemorrhage treated with NovoSeven® to clinical outcomes in women with an event of severe postpartum haemorrhage not treated with NovoSeven®. The study will be a single centre retrospective cohort study of women with an event of severe postpartum haemorrhage, defined as 1.5 L of blood loss within 24 hours of delivery, in the period of 2005-2016.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Hemorrhage
• Postpartum Hemorrhage
• Severe Postpartum Haemorrhage

• NCT number: NCT04444856
• Study type: Observational
• Source: Novo Nordisk A/S
• Status: Completed
• Start date: June 29, 2020
• Completion date: January 13, 2021